Roche Media 2026年6月7日 ADA: Tolerability ‘not to be underappreciated’ in Roche, Zealand’s amylin obesity prospect - Fierce Biotech
MIURA CO.,LTD. 2026年6月6日 Miura Co., Ltd. 2026 Q4 - Results - Earnings Call Presentation (OTCMKTS:MIURF) 2026-06-06 - Seeking Alpha
10x Genomics News 2026年6月6日 10x Genomics (TXG) Is Up 9.7% After Momentum Rally Despite Weak Fundamentals - What's Changed - simplywall.st
FierceBiotech 2026年6月6日 ADA: Lilly pulls back curtain on impressive triple-G efficacy in patients with obesity, diabetes
Eli Lilly 2026年6月6日 ADA: Lilly pulls back curtain on impressive triple-G efficacy in patients with obesity, diabetes - Fierce Biotech
Cell 2026年6月6日 Deep-sea megafauna co-opts microbial energy metabolism genes to withstand ultra-long starvation
FierceBiotech 2026年6月6日 ADA: Pfizer pads case for berobenatide in obesity, adding validation to Metsera buy
Endpoints News 2026年6月6日 #ADA26: Roche to start Phase 2 petrelintide, enicepatide combo trial this year
FierceBiotech 2026年6月6日 ‘It looks like this hypothesis will pan out’: Cullinan unveils data building case for autoimmune TCEs
10x Genomics News 2026年6月6日 10x Genomics (TXG) Is Up 9.7% After Momentum Rally Despite Weak Fundamentals - What's Changed - Sahm
Brady Corporation 2026年6月6日 Label Maker Market Forecast Points Higher Toward 2035, Driven by Commercial Micro-Enterprise Demand - IndexBox